Tags: EU | Spain | Grifols

Spain's Grifols Buys US Firm Talecris for $4B

Monday, 07 Jun 2010 06:58 AM

Spanish healthcare company Grifols SA said Monday it had acquired Talecris Biotherapeutics, based in North Carolina, for euro3.3 billion ($4 billion) including net debt.

In a statement on its website, Grifols, a leading producer of plasma protein therapies, said the deal would create "a global leader of lifesaving and life-enhancing plasma protein therapeutics."

The company said the acquisition of Talecris is expected to generate approximately euro190 million ($230 million) in operating synergies.

The Spanish company's shares were down 5.6 percent at euro8.7 ($10.5) in midmorning trading in Madrid that saw most companies' shares fall.

Grifols is a holding company specialized in the pharmaceutical-hospital sector and is present in more than 90 countries, the statement said.

Talecris is a worldwide biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders, the statement added.

© Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

   
1Like our page
2Share
Headline
Spanish healthcare company Grifols SA said Monday it had acquired Talecris Biotherapeutics, based in North Carolina, for euro3.3 billion ($4 billion) including net debt.In a statement on its website, Grifols, a leading producer of plasma protein therapies, said the deal...
EU,Spain,Grifols
139
2010-58-07
Monday, 07 Jun 2010 06:58 AM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved